AUSTIN, Texas, Sept. 13, 2022 (SEND2PRESS NEWSWIRE) — Kalyagen is pleased to announce that it will be attending and its founder, Christian Drapeau, will be speaking at the upcoming 8th Annual Biohacking Conference. The conference, which is completely sold out, will be held September 15-17 at The Beverly Hilton in Beverly Hills, California.
Archive | Biotechnology
Press Release: Proteios Technology, Inc. Awarded $1.6 Million NIH SBIR Grant to Commercialize its Multivariate Cell Isolation Technology
By Send2Press Newswire on September 8, 2022 in Biotechnology, Business, Funding and Investment, Press Releases, SEATTLE, Wash.
SEATTLE, Wash., Sept. 8, 2022 (SEND2PRESS NEWSWIRE) — Proteios Technology, Inc. is pleased to announce it’s received a $1.6 million SBIR Phase II grant from the National Institutes of Health (NIH) to commercialize its multivariate (parallel) cell isolation technology. Grant funds will be used to extend Proteios’ cell isolation kits to include up to 20 […]
Press Release: Kalyagen Announces Attendance at the Fort Lauderdale Open with PGA Associate Jerrel Gill
By Send2Press Newswire on April 29, 2022 in AUSTIN, Texas, Biotechnology, Business, Golf, Press Releases
AUSTIN, Texas, April 29, 2022 (SEND2PRESS NEWSWIRE) — Kalyagen® is pleased to announce that it will be attending the Fort Lauderdale Open as part of its sponsorship of golf professional Jerrel Gill. The Open will be hosted at the Fort Lauderdale Country Club on May 2-3, 2022.
Press Release: Kalyagen Announces Attendance at Paleo f(x) 2022 Conference
AUSTIN, Texas, April 27, 2022 (SEND2PRESS NEWSWIRE) — Kalyagen is pleased to announce that it will be attending and hosting a booth (#121) at the upcoming Paleo f(x)™ 2022 conference to be held in Austin on April 29 – May 1. STEMREGEN® is a unique and patent-pending blend of proprietary plant-based extracts documented to increase […]
Press Release: Oral Vaccine Boosts COVID Immunity: study conducted on nonhuman primates is published in the journal Vaccine
By Send2Press Newswire on April 6, 2022 in Biotechnology, Business, Drugs and Pharmaceuticals, Press Releases
ROCHESTER, Minn., April 6, 2022 (SEND2PRESS NEWSWIRE) — Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced results confirming the activity of an oral vaccine formulation for boosting immunity against SARS-CoV-2. The full study conducted on nonhuman primates is published in the journal Vaccine.
Press Release: Myrio Therapeutics and Pure MHC, LLC Announce Research Collaboration to Develop Novel, Targeted Antibody-Based Cancer Therapies
By Send2Press Newswire on April 6, 2022 in Alliances and Partnerships, Biotechnology, Business, Drugs and Pharmaceuticals, OKLAHOMA CITY, Okla., Press Releases
OKLAHOMA CITY, Okla., AUSTIN, Texas and MELBOURNE, Australia, April 6, 2022 (SEND2PRESS NEWSWIRE) — Pure MHC, LLC and Myrio Therapeutics Pty Ltd (Myrio) today announced a collaboration to develop new antibody-based oncology therapeutics. The companies will combine Pure MHC’s proprietary offering of MHC peptide targets for oncology with Myrio’s revolutionary Retained Display(tm) (ReD) antibody discovery […]
Press Release: Neurosoft Bioelectronics Receives Nearly $3 Million in Funding
By Send2Press Newswire on April 5, 2022 in Biotechnology, Business, Funding and Investment, NEW YORK, N.Y., Press Releases, Switzerland, Technology
GENEVA, Switzerland, and NEW YORK, N.Y., April 5, 2022 (SEND2PRESS NEWSWIRE) — Neurosoft Bioelectronics, an early-stage company developing tools for unmet needs in epilepsy and tinnitus, was awarded nearly $3 million USD, from the SERI-Funded European Innovation Council Accelerator Grant and a share of the $165,000 USD through the European Research Council Proof-of-Concept Grant.
Press Release: Key Entrepreneurs to Present at 2022 Bioelectronic Medicine Forum
By Send2Press Newswire on March 28, 2022 in Biotechnology, Business, NEW YORK, N.Y., Press Releases, Regional Events, Surgery and Neurotechnology, Technology
NEW YORK, N.Y., March 28, 2022 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that founders and CEOs of several promising bioelectronic medicine startups will present at the Fifth Annual Bioelectric Medicine Forum on April 5, 2022. The event will take place in New York […]
Press Release: Kalyagen Announces Supporting Partnership of Two South Florida PGA Events and PGA Associate Jerrel Gill
By Send2Press Newswire on March 10, 2022 in Alliances and Partnerships, AUSTIN, Texas, Biotechnology, Business, Golf, Press Releases, Sports and Activities
AUSTIN, Texas, March 10, 2022 (SEND2PRESS NEWSWIRE) — Kalyagen® is pleased to announce that it is a supporting partner of two upcoming South Florida PGA Section events and golf professional Jerrel Gill. The two events are the South Florida PGA Foundation PGA HOPE Classic on May 12, 2022 and the South Florida Open on June […]
Press Release: Pure Transplant Solutions, LLC and Vall d’Hebron University Hospital Announce Research Collaboration
By Send2Press Newswire on February 15, 2022 in Alliances and Partnerships, AUSTIN, Texas, Biotechnology, Business, Press Releases
AUSTIN, Texas and BARCELONA, Spain, Feb. 15, 2022 (SEND2PRESS NEWSWIRE) — Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with Vall d’Hebron Barcelona Hospital […]